GlassScriptPhysician profile
Herbert M User
NPI 1578592770
$9,296.94
in general payments reported to CMS, 2019-2025
48 companies · $1,496 in 2025
The $1,496 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,736 · 2020: $698 · 2021: $1,955 · 2022: $1,189 · 2023: $1,253 · 2024: $971 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,719.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $928.62 | 2019-2025 | Lithovue, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Janssen Biotech, INC. | $821.10 | 2019-2025 | Erleada |
| Neotract INC. | $614.47 | 2019-2020 | |
| Srs Medical Systems, INC. | $550.11 | 2020-2023 | Urocuff |
| Abbvie INC. | $491.64 | 2021-2025 | Botox |
| Astellas Pharma US INC | $445.55 | 2019-2025 | Xtandi |
| Verity Pharmaceuticals INC. | $439.50 | 2022-2025 | Trelstar, Tlando |
| Bioprotect Medical, INC. | $416.11 | 2024-2025 | Bioprotect Balloon Implant System |
| Travere Therapeutics, INC. | $411.95 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $333.45 | 2019-2023 | Provenge |
| Calyxo, INC. | $311.61 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $304.45 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $283.91 | 2023-2025 | Orgovyx, Gemtesa |
| Antares Pharma, INC. | $255.60 | 2019-2025 | Xyosted |
| Pfizer INC. | $245.29 | 2019-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $161.09 | 2022-2024 | Urolift |
| Olympus America INC. | $153.28 | 2022-2025 | Itind System |
| Urovant Sciences INC | $152.93 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $152.70 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $151.47 | 2021-2025 | |
| Foundation Medicine, INC. | $111.68 | 2021 | |
| Merck Sharp & Dohme LLC | $110.99 | 2020-2023 | Lynparza, Keytruda, Welireg |
| Coloplast Corp | $104.36 | 2020-2025 | Speedicath |
| Myovant Sciences INC. | $104.20 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $103.25 | 2020-2025 | Prolaris |
| Amgen INC. | $100.22 | 2020-2023 | Prolia |
| Genzyme Corporation | $90.99 | 2020-2022 | |
| Blue Earth Diagnostics | $90.04 | 2020-2022 | |
| Tempus Ai, INC | $89.02 | 2024 | |
| Convatec INC. | $71.26 | 2023-2024 | |
| Clarus Therapeutics INC. | $69.83 | 2021 | |
| 180 Medical, INC. | $68.79 | 2021-2023 | |
| Progenics Pharmaceuticals, INC. | $66.30 | 2025 | |
| Ferring Pharmaceuticals INC. | $66.09 | 2019-2024 | Adstiladrin |
| Endo Pharmaceuticals INC. | $65.31 | 2021-2023 | Edex, Aveed, Xiaflex |
| Tolmar, INC. | $51.20 | 2024-2025 | Eligard, Jatenzo |
| Halozyme INC | $39.86 | 2023 | |
| Accord Healthcare, INC. | $38.46 | 2022-2024 | |
| Becton, Dickinson and Company | $33.33 | 2023 | Bard Urinary Drainage Bag |
| Axonics, INC. | $32.24 | 2022 | |
| Angiodynamics, INC. | $28.40 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $27.25 | 2019 | |
| Urogen Pharma, INC. | $21.56 | 2023 | Jelmyto |
| Acerus Pharmaceuticals Corporation | $20.35 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $19.90 | 2020 | |
| Avation Medical, INC. | $19.68 | 2024 | Vivally |
| Cardinal Health 414 LLC | $19.43 | 2022 | |
| Ambu INC. | $8.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert User listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.